BLGO: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	-11,047	-3,803
Credit loss expense	3,849	-
Stock option compensation expense	1,951	1,107
Common stock issued for services	388	333
Bad debt expense	37	37
Ppp loan forgiveness	0	0
Amortization of debt discount	106	67
Amortization of right-of-use operating lease assets	106	55
Amortization of right-of-use finance lease asset	51	33
Operating lease liabilities	-100	-50
Finance lease liability	65	43
(gain) loss on investment in south korean joint venture	9	9
Depreciation expense	112	78
Accounts receivable	1,958	2,368
Inventories	79	114
Prepaid expenses and other assets	-11	-33
Accounts payable and accrued expenses-Entities Excluding Partially Owned Subsidiary	-55	484
Deposits	10	-68
Accounts payable and accrued expenses-Partially Owned Subsidiary	5	144
Contract liabilities	0	0
Net cash used in operating activities	-6,707	-3,948
Equipment purchases	33	0
Proceeds from note receivable	481	192
Net cash provided by (used in) investing activities	448	192
Proceeds from sale of common stock, net of commissions	1,542	793
Proceeds from debt obligation	50	-
Proceeds from warrant exercise	0	0
Proceeds from option exercise	0	0
Proceeds from sale of common stock-Beti Common Stock	0	0
Repayment of debt obligations	18	9
Proceeds from beti unit offering-Biolargo Energy Technologies Inc BETI	100	-
Proceeds from clyra medical preferred series b-Clyra Medical Preferred Stock Series B	2,145	-
Proceeds from clyra medical debt obligations	1,261	1,261
Proceeds from note payable	-	50
Proceeds from warrant exercise-Clyra Medical Technologies	1,894	1,309
Proceeds from sale of common stock-Clyra Medical Common Stock	295	295
Net cash provided by financing activities	7,269	3,699
Net effect of foreign currency translation	-12	-20
Net change in cash	998	-77
Cash and cash equivalents at beginning of period	3,548	-
Cash and cash equivalents at end of period	4,546	-

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

BLGO: the cashflow